State Street’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$182M Buy
2,162,964
+472,778
+28% +$34.3M 0.01% 992
2025
Q4
$128M Buy
1,690,186
+34,638
+2% +$2.18M ﹤0.01% 1217
2025
Q3
$65.8M Buy
1,655,548
+396,290
+31% +$15.1M ﹤0.01% 1593
2025
Q2
$54.7M Sell
1,259,258
-54,492
-4% -$2.07M ﹤0.01% 1632
2025
Q1
$49.1M Sell
1,313,750
-153,364
-10% -$5.93M ﹤0.01% 1645
2024
Q4
$66.5M Buy
1,467,114
+55,475
+4% +$2.83M ﹤0.01% 1577
2024
Q3
$82.9M Sell
1,411,639
-149,723
-10% -$7.17M ﹤0.01% 1435
2024
Q2
$61.4M Buy
1,561,362
+213,565
+16% +$10.4M ﹤0.01% 1554
2024
Q1
$89.6M Buy
1,347,797
+968,527
+255% +$42.3M ﹤0.01% 1379
2023
Q4
$10.6M Buy
379,270
+175,753
+86% +$3.52M ﹤0.01% 2557
2023
Q3
$4.33M Buy
+203,517
New +$4.48M ﹤0.01% 2987

Other funds holding APGE